Antibody Testing in Patients With Neurological and Psychiatric Symptoms

New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.

Related Videos
Related Content

NeuroVoices: Cornelia Drees, MD, on Understanding the Different Advantages of Microburst Vagus Nerve Stimulation

May 31st 2023

Episode 88: 2023 AAN Annual Meeting Highlights

May 5th 2023

NeurologyLive® Brain Games: May 28, 2023

May 28th 2023

Episode 82: Managing Seizures After Ischemic Stroke

February 10th 2023

CBD Shows Benefit as Adjuvant Treatment in Adults With Drug-Resistant Focal Epilepsy

May 26th 2023

NeuroVoices: Cornelia Drees, MD, on The Advantages of Microburst Vagus Nerve Stimulation for Drug-Resistant Epilepsy

May 24th 2023

NeuroVoices: Cornelia Drees, MD, on Understanding the Different Advantages of Microburst Vagus Nerve Stimulation

May 31st 2023

Episode 88: 2023 AAN Annual Meeting Highlights

May 5th 2023

NeurologyLive® Brain Games: May 28, 2023

May 28th 2023

Episode 82: Managing Seizures After Ischemic Stroke

February 10th 2023

CBD Shows Benefit as Adjuvant Treatment in Adults With Drug-Resistant Focal Epilepsy

May 26th 2023

NeuroVoices: Cornelia Drees, MD, on The Advantages of Microburst Vagus Nerve Stimulation for Drug-Resistant Epilepsy

May 24th 2023

NeuroVoices: Cornelia Drees, MD, on Understanding the Different Advantages of Microburst Vagus Nerve Stimulation

May 31st 2023

Episode 88: 2023 AAN Annual Meeting Highlights

May 5th 2023

NeurologyLive® Brain Games: May 28, 2023

May 28th 2023

Episode 82: Managing Seizures After Ischemic Stroke

February 10th 2023

CBD Shows Benefit as Adjuvant Treatment in Adults With Drug-Resistant Focal Epilepsy

May 26th 2023

NeuroVoices: Cornelia Drees, MD, on The Advantages of Microburst Vagus Nerve Stimulation for Drug-Resistant Epilepsy

May 24th 2023
© 2023 MJH Life Sciences

All rights reserved.